Baseline quality of life predicts survival in patients with advanced colorectal cancer
- 1 July 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (10) , 1351-1357
- https://doi.org/10.1016/s0959-8049(02)00098-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Quality-of-Life Scores Predict Outcome in Metastatic but Not Early Breast CancerJournal of Clinical Oncology, 2000
- Compliance in quality of life data: a Norwegian experienceStatistics in Medicine, 1998
- Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer ResearchStatistics in Medicine, 1998
- Ensuring the quality of quality of life data: the Southwest Oncology Group experienceStatistics in Medicine, 1998
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnnals of Oncology, 1996
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II studyEuropean Journal Of Cancer, 1995
- Protracted venous infusion 5-fluorouracil and interferon-α in advanced and refractory colorectal cancerAnnals of Oncology, 1994
- Prognostic factors for patients with inoperable non-small cell lung cancer, limited diseaseRadiotherapy and Oncology, 1989